Shaily Engineering Plastics share price today

Shaily Engineering Plastics Ltd's share price was ₹3,046.00 at the close on 6 November 2026. It has been rising for 27 weeks. That is 9.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹1,885 and ₹3,368, and at that close it sat 78% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Shaily Engineering Plastics Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running.

Over the last 11 years the share price moved +2,847% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: foreign funds (FIIs) raised their stake for 9 quarters in a row, revenue up on a year earlier for 12 quarters in a row (every quarter we can compare) and profit up on a year earlier for 12 quarters in a row (every quarter we can compare).

1. Foreign funds (FIIs) raised their stake for 9 quarters in a row

   From 2% to 19.4% of the company by the September 2026 quarter.

2. Revenue up on a year earlier for 12 quarters in a row (every quarter we can compare)

   In the September 2026 quarter revenue was ₹320 crore, +24.5% on a year earlier.

3. Profit up on a year earlier for 12 quarters in a row (every quarter we can compare)

   In the September 2026 quarter profit was ₹61 crore, +19.6% on a year earlier.

   Why: Profit rose because gross margin, the money left after direct costs, recovered to 60%.

   Next results: check whether subsidiaries turn profitable as management expects.

   From the earnings call on 30 Oct 2026.

For July to September 2026 (the quarter ended 30 September 2026), Shaily Engineering Plastics reported revenue of ₹320 crore, up 24.5% from ₹257 crore a year earlier, and a profit of ₹61.0 crore, up 19.6% from ₹51.0 crore.

Shaily Engineering Plastics results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Shaily Engineering Plastics' management discussed these results on a call held on 30 October 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Shaily Engineering Plastics closed at ₹3,046.00 on 6 November 2026, up 23.2% from ₹2,471.95 a year earlier (7 November 2025) and up 700.7% over five years. Its highest weekly close since March 2016 was ₹3,367.70 on 14 August 2026.

Shaily Engineering Plastics share price: then and now

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 6 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

564 weekly closes from 11 March 2016 to 6 November 2026.

6 Nov 2026: Shaily Engineering Plastics closed at ₹3,046.00, down 3.7% on the week and down 0.6% on the month. 30 Oct 2026: Shaily Engineering Plastics held its results call for July to September 2026. Management guided: FY27 device output to exceed 36 million; second pen line begins qualification next week, with December sales possible if successful.

Earlier

• Results for July to September 2026: Revenue up 24.5% and profit up 19.6% on a year earlier.
• 11 Sep 2026: ex-date for a dividend of ₹3 a share.
• Our read, 22 Aug 2026: Healthcare revenue expanded 85% on a year earlier in April to June 2026 to ₹142 crore, reaching roughly 51% of consolidated sales as pen-injector volumes scaled. Additional 25 million pen capacity is planned for end-September 2026, taking installed capacity to approximately 75 million pens annually; Abu Dhabi remains a FY28 capacity option.
• 23 Nov 2023: Share split: face value cut from ₹10 to ₹2 a share (ex-date).

Our read of the business

Healthcare revenue expanded 85% on a year earlier in April to June 2026 to ₹142 crore, reaching roughly 51% of consolidated sales as pen-injector volumes scaled. Additional 25 million pen capacity is planned for end-September 2026, taking installed capacity to approximately 75 million pens annually; Abu Dhabi remains a FY28 capacity option.

April to June 2026: Healthcare Reaches Roughly 51% Mix at ₹142 crore; Additional Pen Capacity Planned for End-September.

Our read after the April to June 2026 results, written 22 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

Shaily Engineering Plastics paid ₹3 a share in regular dividends in the 12 months to 7 November 2026 (1 payment), a yield of 0.10% at the ₹3,046.00 close on 6 November 2026. The last was a dividend of ₹3 a share, ex-date 11 September 2026.

Shaily Engineering Plastics dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Shaily Engineering Plastics Ltd paid out 8% of its profit as dividends in FY26, and it paid a dividend in 3 of its last 5 reported years.

From the NSE corporate-actions record, read 7 November 2026.

On the call for July to September 2026, held on 30 October 2026, Shaily Engineering Plastics' management guided: FY27 device output to exceed 36 million; second pen line begins qualification next week, with December sales possible if successful.

“I am not aware of any generic player in Canada that is not using our product.”Amit Sanghvi, on the call for July to September 2026

What management guided

• FY28 device volume planned around 50 million, +/-15%; explicitly not formal guidance.
• Consumer revenue expected flat in FY27; growth next year depends on geopolitics and global conditions.
• Electronics scale-up: supplies for five new components between Q3-Q4; semiconductor commercial shipments in January to March 2027; initial consumer-electronics capital spending around ₹100 crore (₹80-120 crore)
• Healthcare pipeline: 1-2 innovator wins by end-CY27, revenue 3-4 years later; emergency clinical batches end-2027/earliest production end-CY28; Mira clinical batches 14 months after customer selection.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for July to September 2026, 30 October 2026.

What is changing at Shaily Engineering Plastics, from the latest results and calls: glp-1 delivery device scale-up & capacity ramp, abu dhabi global expansion & geographic diversification and high-precision diversification: semiconductor trays & consumer electronics.

• GLP-1 Delivery Device Scale-Up & Capacity Ramp. Installed pen capacity is planned to reach approximately 75 million units by end-September 2026; FY27 deliveries are expected to exceed 36 million units. ⚠ estimate
• Abu Dhabi Global Expansion & Geographic Diversification. the latest call cited end-FY28 sales and 50-55% capacity commitments or indications. ⚠ estimate
• High-Precision Diversification: Semiconductor Trays & Consumer Electronics. Semiconductor-tray supply is planned for January to March 2027 and consumer-electronics commercial supplies began in January to March 2026. ⚠ estimate
• Healthcare Mix Expansion. Healthcare reached roughly 51% of April to June 2026 revenue, but the 30% Screener operating margin is near the historical margin peak and must be assessed through-cycle. ⚠ estimate

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the April to June 2026 results, written 22 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

Sustained healthcare mix and pricing evidence that keeps consolidated operating margin materially above the 17% normalized level for several quarters, while the additional pen line reaches commercial operation by end-September 2026 without another capacity revision.

Each change stops working if

• GLP-1 Delivery Device Scale-Up & Capacity Ramp: Supplier ramp or factory acceptance testing delays prevent commercial production, or customer supply-chain disruption limits deliveries.
• Abu Dhabi Global Expansion & Geographic Diversification: Customer indications do not convert into contracts, government support does not materialize, or commissioning slips beyond FY28.
• High-Precision Diversification: Semiconductor Trays & Consumer Electronics: Qualification, tooling, or customer absorption does not support commercial scale.
• Healthcare Mix Expansion: Healthcare mix declines, freight and polymer costs cannot be mitigated, or consolidated operating margin moves toward its normalized range.

The main risks

• Geopolitical Contract Loss & Geographic Concentration: An overlay records loss of a large GLP-1 pen contract after Operation Sindoor; Abu Dhabi is not expected to generate commercial sales until end FY28. ⚠ estimate
• Pen Capacity Line Commissioning & Efficiency Friction: The second 25 million pen line is planned for end-September 2026 after the first line previously ran at 45% OEE and 8% rejection. ✓ fact
• Management Consistency Track Record & Guidance Reliability: Seven documented consistency issues include device-volume miss, capacity-timing revisions, and a consumer-segment reversal. ✓ fact
• Consumer Discretionary Segment Demand Drag: Consumer revenue fell 9% in FY26 and 24% on a year earlier to ₹116 crore in April to June 2026 on softer European and US home-furnishings demand. ✓ fact

Our read after the April to June 2026 results, written 22 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

When Shaily Engineering Plastics reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: New pen-line qualification and commercial supply - check whether the ramp clears remaining bottlenecks.

Shaily Engineering Plastics is on 2 of our India lists: Momentum stocks and Small & mid cap stocks.

Shaily Engineering Plastics Ltd earned ₹61.0 Cr of net profit in the Sep 2026 quarter, +19.6% on the same quarter a year earlier. That is the 12th quarter in a row of profit growth. Full-year FY26 profit was ₹170 Cr. Over 4 years profit has grown 48.5% a year on average. That is 19.1% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹51.0 Cr.

For the full year, FY26 profit was ₹170 Cr (+82.8% on the year before).

Why profit moved: revenue changed +24.5% on a year earlier and the margin moved −1.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +30.6% and revenue +18.3%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

FY27-Q1. revenue ₹281 Cr and profit ₹48 Cr as reported.

FY27-Q2. revenue ₹320 Cr and profit ₹61 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Shaily Engineering Plastics Ltd reported ₹320 Cr of revenue in the Sep 2026 quarter, +24.5% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 14.9% a year on average. The last full year, FY26, came in at ₹991 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹1,088 Cr.

FY26 revenue was ₹991 Cr, +25.9% on the year before.

Recent pace: the last four quarters grew +18.3% on average, against 14.9% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +18.3%, against +24.7% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +27.4%, against +59.6% a year (rolling over).

FY27-Q1. revenue ₹281 Cr and profit ₹48 Cr as reported.

FY27-Q2. revenue ₹320 Cr and profit ₹61 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Shaily Engineering Plastics Ltd's operating margin was 30.0% in the Sep 2026 quarter, 1.0 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 15.0% and 28.0%. The latest quarter is above every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. Healthcare mix supports the current margin profile. The deterministic normalization nevertheless puts current OPM at the 95th percentile and normalized OPM at 17%, so the durable-margin conclusion is unproven.

Why the margin moved: operating margin changed −0.5 percentage points on the year while gross margin changed +1.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold.

FY27-Q1. revenue ₹281 Cr and profit ₹48 Cr as reported.

FY27-Q2. revenue ₹320 Cr and profit ₹61 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Over the last 3 years, 134% of Shaily Engineering Plastics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹226 Cr of operating cash against ₹170 Cr of profit. After ₹179 Cr of spending on assets, ₹47.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 134% of profit came in as cash: the cash cycle got 43 days longer between FY22 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 2.7× depreciation over three years. The next section checks what that spending is building.

Shaily Engineering Plastics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 135 days in FY26, up from 92 days in FY22. It spent ₹341 Cr on assets over the last 3 years. Customers take 79 days to pay, and stock sits for 129 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Why this happened. Healthcare device revenue expanded 85% YoY in Q1 FY27 to Rs 142 Cr. The additional 25 million pen line is planned for end-September 2026 and FY27 deliveries are expected to exceed 36 million, subject to partner and customer supply-chain continuity.

At FY26 sales of ₹991 Cr, each day of that cycle ties up about ₹2.7 Cr, so roughly ₹367 Cr is tied up in the business at any time.

FY26: customers took 79 days to pay and stock sat for 129 days, about 4.2 months of sales sitting as stock, for a full cycle of 135 days, longer than FY22's 92.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 129 days. Customers pay about 79 days after that. Suppliers are paid at 74 days. Together that makes the 135-day cycle.

Spending on assets: ₹341 Cr over the last 3 years, against ₹127 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹29.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Shaily Engineering Plastics Ltd's P/E is 75.0×, in the middle of its own history: higher than 54% of past readings. Its usual P/E (the middle reading) is 71.5×, over 4.4 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.